These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
593 related items for PubMed ID: 17190905
1. Bezafibrate regulates the expression and enzyme activity of 11beta-hydroxysteroid dehydrogenase type 1 in murine adipose tissue and 3T3-L1 adipocytes. Nakano S, Inada Y, Masuzaki H, Tanaka T, Yasue S, Ishii T, Arai N, Ebihara K, Hosoda K, Maruyama K, Yamazaki Y, Shibata N, Nakao K. Am J Physiol Endocrinol Metab; 2007 Apr; 292(4):E1213-22. PubMed ID: 17190905 [Abstract] [Full Text] [Related]
2. Dehydroepiandrosterone inhibits the amplification of glucocorticoid action in adipose tissue. Apostolova G, Schweizer RA, Balazs Z, Kostadinova RM, Odermatt A. Am J Physiol Endocrinol Metab; 2005 May; 288(5):E957-64. PubMed ID: 15613680 [Abstract] [Full Text] [Related]
3. Effects of peroxisome proliferator-activated receptor ligands, bezafibrate and fenofibrate, on adiponectin level. Hiuge A, Tenenbaum A, Maeda N, Benderly M, Kumada M, Fisman EZ, Tanne D, Matas Z, Hibuse T, Fujita K, Nishizawa H, Adler Y, Motro M, Kihara S, Shimomura I, Behar S, Funahashi T. Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):635-41. PubMed ID: 17194889 [Abstract] [Full Text] [Related]
4. Role of 11-beta-hydroxysteroid dehydrogenase type 1 in differentiation of 3T3-L1 cells and in rats with diet-induced obesity. Liu Y, Sun WL, Sun Y, Hu G, Ding GX. Acta Pharmacol Sin; 2006 May; 27(5):588-96. PubMed ID: 16626514 [Abstract] [Full Text] [Related]
5. 11β-HSD1 reduces metabolic efficacy and adiponectin synthesis in hypertrophic adipocytes. Koh EH, Kim AR, Kim H, Kim JH, Park HS, Ko MS, Kim MO, Kim HJ, Kim BJ, Yoo HJ, Kim SJ, Oh JS, Woo CY, Jang JE, Leem J, Cho MH, Lee KU. J Endocrinol; 2015 Jun; 225(3):147-58. PubMed ID: 25869616 [Abstract] [Full Text] [Related]
6. Type 2 diabetes and metabolic syndrome are associated with increased expression of 11beta-hydroxysteroid dehydrogenase 1 in obese subjects. Alberti L, Girola A, Gilardini L, Conti A, Cattaldo S, Micheletto G, Invitti C. Int J Obes (Lond); 2007 Dec; 31(12):1826-31. PubMed ID: 17593901 [Abstract] [Full Text] [Related]
7. 17Beta-estradiol inhibits 11beta-hydroxysteroid dehydrogenase type 1 activity in rodent adipocytes. Tagawa N, Yuda R, Kubota S, Wakabayashi M, Yamaguchi Y, Kiyonaga D, Mori N, Minamitani E, Masuzaki H, Kobayashi Y. J Endocrinol; 2009 Jul; 202(1):131-9. PubMed ID: 19380458 [Abstract] [Full Text] [Related]
8. Pan-PPAR agonist beneficial effects in overweight mice fed a high-fat high-sucrose diet. Fernandes-Santos C, Carneiro RE, de Souza Mendonca L, Aguila MB, Mandarim-de-Lacerda CA. Nutrition; 2009 Jul; 25(7-8):818-27. PubMed ID: 19268533 [Abstract] [Full Text] [Related]
9. Resveratrol inhibits 11β-hydroxysteroid dehydrogenase type 1 activity in rat adipose microsomes. Tagawa N, Kubota S, Kato I, Kobayashi Y. J Endocrinol; 2013 Sep; 218(3):311-20. PubMed ID: 23814014 [Abstract] [Full Text] [Related]
10. Suppression of 11beta-hydroxysteroid dehydrogenase type 1 with RNA interference substantially attenuates 3T3-L1 adipogenesis. Liu Y, Park F, Pietrusz JL, Jia G, Singh RJ, Netzel BC, Liang M. Physiol Genomics; 2008 Feb 19; 32(3):343-51. PubMed ID: 18073273 [Abstract] [Full Text] [Related]
11. Anti-diabetic and anti-adipogenic effects of a novel selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor, 2-(3-benzoyl)-4-hydroxy-1,1-dioxo-2H-1,2-benzothiazine-2-yl-1-phenylethanone (KR-66344). Park JS, Rhee SD, Kang NS, Jung WH, Kim HY, Kim JH, Kang SK, Cheon HG, Ahn JH, Kim KY. Biochem Pharmacol; 2011 Apr 15; 81(8):1028-35. PubMed ID: 21315688 [Abstract] [Full Text] [Related]
12. Anti-diabetic and anti-adipogenic effects of a novel selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor in the diet-induced obese mice. Park JS, Rhee SD, Jung WH, Kang NS, Kim HY, Kang SK, Ahn JH, Kim KY. Eur J Pharmacol; 2012 Sep 15; 691(1-3):19-27. PubMed ID: 22760069 [Abstract] [Full Text] [Related]
13. Effect of PPAR-delta agonist on the expression of visfatin, adiponectin, and resistin in rat adipose tissue and 3T3-L1 adipocytes. Choi KC, Lee SY, Yoo HJ, Ryu OH, Lee KW, Kim SM, Baik SH, Choi KM. Biochem Biophys Res Commun; 2007 May 25; 357(1):62-7. PubMed ID: 17418807 [Abstract] [Full Text] [Related]
14. Effects of a high-salt diet on adipocyte glucocorticoid receptor and 11-beta hydroxysteroid dehydrogenase 1 in salt-sensitive hypertensive rats. Usukura M, Zhu A, Yoneda T, Karashima S, Yagi K, Yamagishi M, Takeda Y. Steroids; 2009 Nov 25; 74(12):978-82. PubMed ID: 19646461 [Abstract] [Full Text] [Related]
15. Regulation of 11beta-HSD genes in human adipose tissue: influence of central obesity and weight loss. Engeli S, Böhnke J, Feldpausch M, Gorzelniak K, Heintze U, Janke J, Luft FC, Sharma AM. Obes Res; 2004 Jan 25; 12(1):9-17. PubMed ID: 14742837 [Abstract] [Full Text] [Related]
16. 11β-Hydroxysteroid dehydrogenase type 1 shRNA ameliorates glucocorticoid-induced insulin resistance and lipolysis in mouse abdominal adipose tissue. Wang Y, Yan C, Liu L, Wang W, Du H, Fan W, Lutfy K, Jiang M, Friedman TC, Liu Y. Am J Physiol Endocrinol Metab; 2015 Jan 01; 308(1):E84-95. PubMed ID: 25389364 [Abstract] [Full Text] [Related]
17. Glucocorticoid reamplification within cells intensifies NF-kappaB and MAPK signaling and reinforces inflammation in activated preadipocytes. Ishii-Yonemoto T, Masuzaki H, Yasue S, Okada S, Kozuka C, Tanaka T, Noguchi M, Tomita T, Fujikura J, Yamamoto Y, Ebihara K, Hosoda K, Nakao K. Am J Physiol Endocrinol Metab; 2010 May 01; 298(5):E930-40. PubMed ID: 19776225 [Abstract] [Full Text] [Related]
18. Augmentation of 11beta-hydroxysteroid dehydrogenase type 1 in LPS-activated J774.1 macrophages--role of 11beta-HSD1 in pro-inflammatory properties in macrophages. Ishii T, Masuzaki H, Tanaka T, Arai N, Yasue S, Kobayashi N, Tomita T, Noguchi M, Fujikura J, Ebihara K, Hosoda K, Nakao K. FEBS Lett; 2007 Feb 06; 581(3):349-54. PubMed ID: 17239856 [Abstract] [Full Text] [Related]
19. Alternative mechanism for anti-obesity effect of dehydroepiandrosterone: possible contribution of 11β-hydroxysteroid dehydrogenase type 1 inhibition in rodent adipose tissue. Tagawa N, Minamitani E, Yamaguchi Y, Kobayashi Y. Steroids; 2011 Dec 20; 76(14):1546-53. PubMed ID: 21945397 [Abstract] [Full Text] [Related]
20. Rosiglitazone decreases 11beta-hydroxysteroid dehydrogenase type 1 in subcutaneous adipose tissue. Mai K, Andres J, Bobbert T, Maser-Gluth C, Möhlig M, Bähr V, Pfeiffer AF, Spranger J, Diederich S. Clin Endocrinol (Oxf); 2007 Sep 20; 67(3):419-25. PubMed ID: 17555498 [Abstract] [Full Text] [Related] Page: [Next] [New Search]